Filing Details
- Accession Number:
- 0001264124-12-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-10 20:55:09
- Reporting Period:
- 2012-02-08
- Filing Date:
- 2012-02-10
- Accepted Time:
- 2012-02-10 20:55:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881464 | Amylin Pharmaceuticals Inc | AMLN | Pharmaceutical Preparations (2834) | 330266089 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236394 | G Orville Kolterman | 9360 Towne Centre Dr San Diego CA 92121 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-08 | 15,000 | $0.00 | 171,457 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2012-02-08 | 5,637 | $16.62 | 165,820 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,767 | Indirect | Indirect-401k |
| Common Stock | 6,445 | Indirect | by ESOP |
Footnotes
- Represents shares acquired upon vesting of performance-based restricted stock units.
- Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units.
- These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
Billionaire Hedge Funds
